Camel antibodies for PSA assays
نویسندگان
چکیده
منابع مشابه
Quantification Analysis of Dot Blot Assays for Human Immunodeficiency Virus Type 1 and 2 Antibodies
Objective Dot Blot (DB) assay provides highly specific results, but usually not reliable for quantification of antibody production. The need for a more objective DB assay to provide a better definition of the immune status, against HIV antigens, promoted this study to be done to develop a quantitative DB assay. Material and Methods Dot blot (DB) strips for antibodies directed to human immuno...
متن کاملSingle domain camel antibodies: current status.
The antigen-binding capacity of the paired variable domains of an antibody is well established. The observation that the isolated heavy chains of anti-hapten antibodies retain some antigen-binding capacity in the absence of light chains led to attempts to obtain an even smaller antigen-binding unit in a VH format. Unfortunately, the poor solubility, the reduced affinity for the antigen and the ...
متن کاملRecombinant Antibodies as Standards for Immunodiagnostic Assays
performance of immunodiagnostic assays and can vary from lab to lab according to factors such as assay reagents used, variation in the level of automation, operator experience and sample throughput. The quality and stability of assay components are critical to success. An important choice during assay development is the source of control and/or calibrator material and its standardization. Lack ...
متن کاملSensitivity of assays for TSH-receptor antibodies
Hashimoto’s patients have in some cases both stimulating and blocking antibodies [2, 3]. It stands to reason that if the patient is hypothyroid, then blocking antibody avidity and/ or titer would dominate irrespective of the presence of stimulating antibodies. There is a growing list of publications that show the prevalence of TSHR stimulating autoantibodies in HT patients using bioassays. Wall...
متن کاملComparison of prostate-specific antigen (PSA) measured by four combinations of free PSA and total PSA assays.
We compared prostate-specific antigen (PSA) assay systems [i.e., free PSA (f-PSA) and the corresponding total PSA (t-PSA) assay] from four different manufacturers as well as the f-PSA/t-PSA ratios with regard to their ability to discriminate between benign prostate hyperplasia (BPH) and prostate cancer (PCA). ROC analysis showed similar areas under the curves (AUCs) with different assay systems...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Analytical Chemistry
سال: 2005
ISSN: 0003-2700,1520-6882
DOI: 10.1021/ac0535234